InsidersTradesSigma
Track the PHARMANUTRA CS share price and the full directors' dealings record of the company, a listed issuer based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA CS has published 1 public disclosures. Market capitalisation: €804.3m. The latest transaction was reported on 24 July 2024 (Other). Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,444 of 29,064 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
Acerca de PHARMANUTRA CS
PHARMANUTRA CS es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XMIL. Se centra en el desarrollo y la comercialización de productos nutracéuticos y farmacéuticos.